# Long-term Oxygen Treatment Trial

> **NCT00692198** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 738 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Supplemental oxygen therapy

## Key facts

- **NCT ID:** NCT00692198
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 738 (ACTUAL)
- **Last updated:** 2017-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692198, "Long-term Oxygen Treatment Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00692198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*